HAMILTON, Bermuda, Jan. 02, 2024 (GLOBE NEWSWIRE) Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the 42nd Annual.
Michael Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA), has sold 9,316 shares of the company on December 19, 2023, according to a recent SEC Filing.
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s stock price was up 4.9% during trading on Friday . The company traded as high as $17.93 and last traded at $17.89. Approximately 343,888 shares changed hands during trading, a decline of 18% from the average daily volume of 418,446 shares. The stock had previously closed at […]
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) insider John F. Paolini sold 28,600 shares of the company’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $17.65, for a total transaction of $504,790.00. Following the sale, the insider now directly owns 44,892 shares in the company, […]